首页 | 本学科首页   官方微博 | 高级检索  
     

肝脏储备功能相关系统对肝硬化失代偿期预后的评估与分析
引用本文:区映研,李晓霞,曾文铤,梁建新. 肝脏储备功能相关系统对肝硬化失代偿期预后的评估与分析[J]. 国际医药卫生导报, 2012, 18(3): 333-337
作者姓名:区映研  李晓霞  曾文铤  梁建新
作者单位:1. 广州,广州医学院第一附属医院感染内科
2. 广州,广州医学院第一附属医院内科
摘    要:目的运用终末期肝病模型(MELD)评分与CTP分级等对失代偿期肝硬化患者短期生存状况进行相关性回顾性分析,预测失代偿期肝硬化患者3个月、1年的病死率。方法应用MELD、MELD—Na计算公式及CTP分级分别对119例肝硬化失代偿期患者进行评分及分级,比较不同MELD评分(≤9、10~19、20~29、≥30分)组及CTP不同分级患者(A、B、C级)3月和1年的病死率,并分析肝硬化失代偿期患者随访3月、1年预后的临床特征。结果MELD评分≤9、10~19、20.29、≥30分者,3个月内死亡率分别为:2.17%,10.71%、64.29%和100%;1年病死率分别为:26.09%、32.14%、57.14%和100%,各组间差异有显著性(3月组P〈0.05,1年组P〈0.01)。表明肝硬化失代偿期患者短期(3月与1年)病死率与MELD分值有关。以R〉18分为界分组比较3月、1年的病死率,结果显示〉18分的3月、1年病死率明显高于≤18分组,差异有极显著性(两组P〈0.01)。CTP分级显示:A、B、C级3个月内各组死亡率分别为6.78%、15.38%、42.86%,各组差异有极显著性(P〈0.01)。1年病死率分别

关 键 词:肝硬化失代偿期患者  肝脏储备功能  预后  MELD评分  肝硬化患者  年病死率  终末期肝病模型  评估

Liver reserve function for assessing and analyzing prognosis of decompensated hepatocirrhosis
OU Ying-yan , LI Xiao-xia , ZENG Wen-ting , LIANG Jian-xin. Liver reserve function for assessing and analyzing prognosis of decompensated hepatocirrhosis[J]. International Medicine & Health Guidance News, 2012, 18(3): 333-337
Authors:OU Ying-yan    LI Xiao-xia    ZENG Wen-ting    LIANG Jian-xin
Affiliation:.Department of Infeetious Diseases, First Affiliated Hospital, Guangzhou Medical College, Guangzhou 510120, China
Abstract:Objective To retrospectively analyze the short-term survival status of decompensated hepatocirrhosis by the Model for End-Stage Liver Disease ( MELD ) and Child-Turcotte-Pugh ( CTP ) score and to predict 3-month and one-year mortality rates in decompensated hepatocirrhosis. Methods MELD, MELD-Na, and CTP score decompensated hepatocirrhosis were used to classify and graded decompensated hepatocirrhosis in 119 patients.The 3-month and one-year morality rates were compared among patients with different MELD scores ( ≤9, 10-19, 20-29, and ≥30 ) or different CTP classification ( A, B, and C ). The clinical features were analyzed in the patienes during a 3- month and a one-year follow-up. Results The 3-month mortality rate was 2.17 % for MELD ≤ 9, 10.71% for 10-19, 64.29 % for 20-29, and 100 % for I〉30; and the one-year mortality was 26.09%, 32.14%, 57.14 %, and 100 %, respectively. The short-term mortality was associated with MELD scores. If R 〉 18 was used as a standard, the 3-month and one-year mortality rates were significantly higher in the group with R 〉 18 than in the group with R= 18 ( P〈 0.01 for both comparisons ). The 3-month mortality rate was 6.78 % for CTP A, 15.38 % for B, and 42.86 % for C ( P〈 0.01 and the one-year mortality was 11.86 %, 38.46 %, and 90.48 %, respectively ( P〈 0.05 ). MELD-Na was related to the short-term mortality ( 3 months and 1 year ) in decompenated hepatocirrosis ( P 〈 0.01 ). Conclusions Both MELD and CTP scores can accurately predict the short-term prognosis in patients with decompensated hepatocirrhosis.
Keywords:Hepatocirrhosis  Model for End-Stage Liver Diseas Child-Turcotte-Pugh score
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号